Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

about

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

Item

http://www.wikidata.org/entity/Q47199775

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@en

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@nl

type

Item

label

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@en

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@nl

prefLabel

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@en

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@nl

P1476

Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosa.

@en

P2093

Bin Cheng

http://www.w3.org/2001/XMLSchema#string

Da Ma

http://www.w3.org/2001/XMLSchema#string

Juan Fang

http://www.w3.org/2001/XMLSchema#string

Juan Xia

http://www.w3.org/2001/XMLSchema#string

Liqun Luo

http://www.w3.org/2001/XMLSchema#string

Qiusheng Li

http://www.w3.org/2001/XMLSchema#string

Xi Wang

http://www.w3.org/2001/XMLSchema#string

Xiangqi Liu

http://www.w3.org/2001/XMLSchema#string

Xinye Li

http://www.w3.org/2001/XMLSchema#string

Yichen Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Immunotherapy for head and neck squamous cell carcinoma

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Restoring function in exhausted CD8 T cells during chronic viral infection

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Cancer immunotherapy comes of age

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

P304

e1388484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1388484

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

V W Lui

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29308315

http://www.w3.org/2001/XMLSchema#string

P932

5749661

http://www.w3.org/2001/XMLSchema#string